[Soor prevention in premature infants. I. Effectiveness of nystatin in healthy newborn infants].
D000367:Age Factors; D002177:Candidiasis / Q000517:prevention & control*; D002179:Candidiasis, Cutaneous / Q000517:prevention & control; D002180:Candidiasis, Oral / Q000517:prevention & control; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D009059:Mouth Diseases / Q000517:prevention & control; D009761:Nystatin / Q000627:therapeutic use*; D012007:Rectum / Q000382:microbiology; D012867:Skin / Q000382:microbiology
D009761:Nystatin
Untersuchungen zur Soorprophylaxe Neugeborener. I. Wirksamkeit einer Fungicidin-(Nystatin-)-Prophylaxe bei gesunden Neugeborenen